Endovascular treatment of critical ischemia in the diabetic foot: New thresholds, new anatomies

Angiology

Volumn 64, Issue 8, 2013, Pages 583-591

  Georgakarakos, Efstratios ^a   Papanas, Nikolaos ^b   Papadaki, Evaggelia ^a   Georgiadis, George S ^a   Maltezos, Efstratios ^b   Lazarides, Miltos K ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

angiosome; critical limb ischemia; diabetes; endovascular; ulcer; wound healing

Indexed keywords

ANGIOPLASTY; ANKLE; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DIABETIC FOOT; HUMAN; KNEE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVASCULARIZATION; REVIEW; STENT;

ANGIOSOME; CRITICAL LIMB ISCHEMIA; DIABETES; ENDOVASCULAR; ULCER; WOUND HEALING;

ANGIOPLASTY; COMORBIDITY; DIABETIC FOOT; ENDOVASCULAR PROCEDURES; HUMANS; ISCHEMIA; LIMB SALVAGE; PERIPHERAL VASCULAR DISEASES; STENTS; THIGH; VASCULAR PATENCY; WOUND HEALING;

EID: 84885051982     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712465172     Document Type: Review

References (86)

1. Vamos EP, Bottle A, Edmonds ME, Valabhji J, Majeed A, Millett C. Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care. 2010 ; 33 (12). 2592-2597
2. Papanas N, Maltezos E, Edmonds M. Salvation of the. Vasa. 2011 ; 40 (4). 267-269
3. Papanas N, Lazarides MK. Diabetic foot amputations in Greece: where do we go from here?. Int J Low Extrem Wounds. 2011 ; 10 (1). 4-5
4. Papanas N, Maltezos E. The diabetic foot: a global threat and a huge challenge for Greece. Hippokratia. 2009 ; 13 (4). 199-204
5. Faglia E, Clerici G, Clerissi J, et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care. 2009 ; 32 (5). 822-827
6. Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes - a review. Diabet Med. 2010 ; 27 (1). 4-14
7. Faglia E, Clerici G, Caminiti M, et al. Mortality after major amputation in diabetic patients with critical limb ischemia who did and did not undergo previous peripheral revascularization data of a cohort study of 564 consecutive diabetic patients. J Diabetes Complications. 2010 ; 24 (4). 265-269
8. Diabetes Care. 1999: 1354-1360.
9. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005 ; 29 (6). 620-627
10. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med. 2002 ; 252 (3). 225-232
11. Gerassimidis T, Karkos CD, Karamanos D, Kamparoudis A. Current endovascular management of the ischaemic diabetic foot. Hippokratia. 2008 ; 12 (2). 67-73
12. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007 ; 33 (4). 453-460
13. Tsuchiya M, Suzuki E, Egawa K, et al. Abnormal peripheral circulation in type 2 diabetic patients with normal ankle-brachial index associates with coronary atherosclerosis, large artery stiffness, and peripheral vascular resistance. Diabetes Res Clin Pract. 2005 ; 70 (3). 253-262
14. Tsuchiya M, Suzuki E, Egawa K, et al. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care. 2004 ; 27 (10). 2409-2415
15. Suzuki E, Yoshimura T, Omura Y, et al. Higher arterial stiffness, greater peripheral vascular resistance and lower blood flow in lower-leg arteries are associated with long-term hyperglycaemia in type 2 diabetic patients with normal ankle-brachial index. Diabetes Metab Res Rev. 2009 ; 25 (4). 363-369
16. Timmins LH, Meyer CA, Moreno MR, Moore JE. Effects of stent design and atherosclerotic plaque composition on arterial wall biomechanics. J Endovasc Ther. 2008 ; 15 (6). 643-654
17. Carrozza JP, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993 ; 118 (5). 344-349
18. Neubauer B, Gundersen HJ. Calcifications, narrowing and rugosities of the leg arteries in diabetic patients. Acta Radiol Diagn (Stockh). 1983 ; 24 (5). 401-413
19. MacSween RN. Diabetic angiopathy. Scott Med J. 1971 ; 16 (7). 327-335
20. de Haas WH.. "Footnotes" on diabetes, with special reference to calcification of the metatarsal arteries. Folia Med Neerl. 1969 ; 12 (5). 201-211
21. Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds. 2011 ; 10 (3). 152-166
22. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007 ; 45 (suppl S). S5 - S67
23. Cotroneo AR, Iezzi R. The role of "cutting" balloon angioplasty for the treatment of short femoral bifurcation steno-obstructive disease. Cardiovasc Intervent Radiol. 2010 ; 33 (5). 921-928
24. Donas KP, Pitoulias GA, Schwindt A, et al. Endovascular treatment of profunda femoris artery obstructive disease: nonsense or useful tool in selected cases?. Eur J Vasc Endovasc Surg. 2010 ; 39 (3). 308-313
25. Dormandy JA, Rutherford RB.. Management of peripheral arterial disease (PAD). TASC working group. Transatlantic inter-society consensus (TASC). J Vasc Surg. 2000 ; 31 (1 pt 2). S1 - S296
26. Lazaris AM, Tsiamis AC, Fishwick G, Bolia A, Bell PR. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischemia. J Endovasc Ther. 2004 ; 11 (4). 447-453
27. Gray BH, Grant AA, Kalbaugh CA, et al. The impact of isolated tibial disease on outcomes in the critical limb ischemic population. Ann Vasc Surg. 2010 ; 24 (8). 349-359
28. Werneck CC, Lindsay TF. Tibial angioplasty for limb salvage in high-risk patients and cost analysis. Ann Vasc Surg. 2009 ; 23 (5). 554-559
29. Lazaris AM, Salas C, Tsiamis AC, et al. Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg. 2006 ; 32 (6). 668-674
30. Adam DJ, Beard JD, Cleveland T, et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 ; 366 (9501). 1925-1934
31. Bradbury AW, Adam DJ, Bell J, et al. BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010 ; 51 (5 suppl). 5S - 17S
32. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010 ; 51 (5 suppl). 18S - 31S
33. Nolan BW, De Martino RR, Stone DH, et al. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg. 2011 ; 54 (3). 730-735
34. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008 ; 47 (5). 975-981
35. Fernandez N, McEnaney R, Marone LK, et al. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg. 2011 ; 54 (3). 722-729
36. Fernandez N, McEnaney R, Marone LK, et al. Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg. 2010 ; 52 (4). 834-842
37. Sadek M, Ellozy SH, Turnbull IC, Lookstein RA, Marin ML, Faries PL. Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg. 2009 ; 49 (3). 638-643
38. Jacqueminet S, Hartemann-Heurtier A, Izzillo R, et al. Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors. Diabetes Metab. 2005 ; 31 (4 pt 1). 370-375
39. Hering J, Angelkort B, Keck N, Wilde J, Amann B. Long-term outcome of successful percutaneous transluminal angioplasty of the fibular artery in diabetic foot syndrome and single-vessel calf perfusion depends on doppler wave pattern at the forefoot. Vasa. 2010 ; 39 (1). 67-75
40. Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg. 2003 ; 37 (2). 307-315
41. Zhu YQ, Zhao JG, Liu F, et al. Subintimal angioplasty for below-The-ankle arterial occlusions in diabetic patients with chronic critical limb ischemia. J Endovasc Ther. 2009 ; 16 (5). 604-612
42. Skoutas D, Papanas N, Georgiadis GS, et al. Risk factors for ipsilateral reamputation in patients with diabetic foot lesions. Int J Low Extrem Wounds. 2009 ; 8 (2). 69-74
43. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007 ; 115 (21). 2745-2749
44. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007 ; 116 (3). 285-292
45. Laird JR, Katzen BT, Scheinert D, et al. RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010 ; 3 (3). 267-276
46. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006 ; 13 (6). 701-710
47. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005 ; 16 (3). 331-338
48. Donas KP, Torsello G, Schwindt A, Schönefeld E, Boldt O, Pitoulias GA. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg. 2010 ; 52 (2). 356-361
49. Donas KP, Schwindt A, Schönefeld T, Tessarek J, Torsello G. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice. Eur J Vasc Endovasc Surg. 2009 ; 37 (6). 688-693
50. Falkowski A, Poncyljusz W, Wilk G, Szczerbo-Trojanowska M. The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol. 2009 ; 19 (4). 966-974
51. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011 ; 18 (1). 1-12
52. Kawarada O, Yokoi Y, Higashimori A, et al. Stent-assisted below-The-ankle angioplasty for limb salvage. J Endovasc Ther. 2011 ; 18 (1). 32-42
53. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009 ; 16 (suppl 1). I153 - I162
54. Alexandrescu V, Hubermont G. Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist?. Diabetes Metab Syndr Obes. 2011 ; 4: 327-336
55. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg. 1987 ; 40 (2). 113-141
56. Taylor GI, Pan WR. Angiosomes of the leg: anatomic study and clinical implications. Plast Reconstr Surg. 1998 ; 102 (3). 599-616
57. Georgakarakos E, Kapoulas K, Koukoumtzis D, Mantatzis M, Lazarides MK. An uncommon clinical presentation of acute limb ischemia: underscoring the role of perigenicular collaterals. Vascular. 2012 ; 20 (3). 174-177
58. Alexandrescu VA, Hubermont G, Philips Y, et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008 ; 15 (5). 580-593
59. Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter?. Ann Vasc Surg. 2009 ; 23 (3). 367-373
60. Iida O, Nanto S, Uematsu M, et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010 ; 75 (6). 830-836
61. Iida O, Soga Y, Hirano K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-The-knee lesions. Vasc Surg. 2012 ; 55 (2). 363-370
62. Alexandrescu V, Hubermont G, Philips Y, et al. Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service. Eur J Vasc Endovasc Surg. 2009 ; 37 (4). 448-456
63. Alexandrescu V, Vincent G, Azdad K, et al. A reliable approach to diabetic neuroischemic foot wounds: below-The-knee angiosome-oriented angioplasty. J Endovasc Ther. 2011 ; 18 (3). 376-387
64. Schneider PA, Caps MT, Ogawa DY, Hayman ES. Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg. 2001 ; 33 (5). 955-962
65. Conte MS.. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Vasc Surg. 2010 ; 52 (3 suppl). 96S - 103S
66. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008 ; 51 (5). 747-755
67. DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg. 2008 ; 47 (1). 101-108
68. Awad S, Karkos CD, Serrachino-Inglott F, et al. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. Eur J Vasc Endovasc Surg. 2006 ; 32 (1). 51-59
69. Lazarides MK. The impact of interventional management on healing of ischemic foot lesions. Int J Low Extrem Wounds. 2009 ; 8 (2). 64-66
70. Bradbury AW, Adam DJ, Bell J, et al. BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the Trans Atlantic Inter-Society Consensus II classification. J Vasc Surg. 2010 ; 51 (5 suppl). 32S - 42S
71. Lepäntalo M, Apelqvist J, Setacci C, et al. Chapter V: diabetic foot. Eur J Vasc Endovasc Surg. 2011 ; 42 (suppl 2). S60 - S74
72. Rogers LC, Andros G, Caporusso J, Harkless LB, Mills JL, Armstrong DG. Toe and flow: essential components and structure of the amputation prevention team. J Am Podiatr Med Assoc. 2010 ; 100 (5). 342-348
73. Jeffcoate W, Edmonds M, Rayman G, Shearman C, Stuart L, Turner B. Putting feet first - national guidance at last. Diabet Med. 2009 ; 26 (11). 1081-1082
74. Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N, Sasajima T. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?. Eur J Vasc Endovasc Surg. 2012 ; 43 (3). 322-328
75. Papanas N, Maltezos E, Edmonds M. St. Vincent declaration after 15 years or who cleft the devil's foot?. Vasa. 2006 ; 35 (1). 3-4
76. Papanas N, Maltezos E, Edmonds M. The diabetic foot: a plea for the elementary?. Acta Diabetol. 2006 ; 43 (4). 152-153
77. Papanas N, Maltezos E. The diabetic foot: established and emerging treatments. Acta Clin Belg. 2007 ; 62 (4). 230-238
78. Nair DG, Samson R. Which diabetics are at risk for lower-extremity problems and what preventive measures can be taken?. Semin Vasc Surg. 2008 ; 21 (3). 154-159
79. Paraskevas KI, Baker DM, Pompella A, Mikhailidis DP. Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview. Ann Vasc Surg. 2008 ; 22 (3). 481-491
80. Cheshire NJ, Wolfe JH, Barradas MA, Chambler AW, Mikhailidis DP. Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis. Eur J Vasc Endovasc Surg. 1996 ; 11 (4). 479-486
81. Fatourou EM, Paraskevas KI, Seifalian AM, Hamilton G, Mikhailidis DP. The role of established and emerging risk factors in peripheral vascular graft occlusion. Expert Opin Pharmacother. 2007 ; 8 (7). 901-911
82. Tiaka EK, Papanas N, Manolakis AC, Maltezos E. The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers. Int J Burns Trauma. 2011 ; 1 (1). 68-76
83. Tiaka EK, Papanas N, Manolakis AC, Maltezos E. The role of hyperbaric oxygen in the treatment of diabetic foot ulcers. Angiology. 2012 ; 63 (4). 302-314
84. Tiaka EK, Papanas N, Manolakis AC, Georgiadis GS. Epidermal growth factor in the treatment of diabetic foot ulcers: an update. Perspect Vasc Surg Endovasc Ther. 2012 ; 24 (1). 37-44
85. Paraskevas KI, Wierzbicki AS, Mikhailidis DP. Statins and noncardiac vascular disease. Curr Opin Cardiol. 2012 ; 27 (4). 392-397
86. Robless P, Mikhailidis DP, Stansby GP.. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008 ; (1). CD003748